Last reviewed · How we verify
NCT04266782: ParKInWalk
ParKinWalk: Physical Activity and Long Group-walking for Parkinson's Disease
NA trial testing Exercise program followed by long walk in group in Parkinson Disease in 40 participants. Completed in 1 February 2020.
30 November 2019
Quick facts
| Lead sponsor | Università degli Studi di Brescia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 May 2019 |
| Primary completion | 30 November 2019 |
| Estimated completion | 1 February 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Exercise program followed by long walk in group
- Exercise program followed by long walk in group (controls)
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Healthy Aging — all drugs for Healthy Aging →
Sponsor
Università degli Studi di Brescia — full company profile →
Who can join
Adults 30 to 80, any sex, with Parkinson Disease or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will evaluate the impact of exercise training program followed by long-walking onon supervised and unsupervised gait assessment in Parkinson´s disease and control subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04266782
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Università degli Studi di Brescia trials
Trials by the same sponsor.
- NCT07316413 — Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration · NA · recruiting
- NCT07275398 — Experimental Study on Exercise and Well-being in University Students · NA · completed
- NCT05705037 — MIH and Hypersensitivity in Children · NA · unknown
- NCT05045105 — Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians · unknown
- NCT04441866 — Automated Analysis Algorithms in Second Trimester Obstetric Ultrasound · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04266782 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Università degli Studi di Brescia
- Last refreshed: 12 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04266782.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing